| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $55.3B | $53.6B | $53.7B | $63.0B | $63.5B | $56.6B | $58.8B | $58.5B |
| Cost of Revenue | $43.9B | $41.7B | $42.2B | $50.6B | $50.1B | $46.2B | $47.6B | $47.8B |
| Gross Profit | $11.4B | $11.8B | — | — | — | — | — | — |
| R&D Expense | $1.6B | $1.6B | $1.6B | $1.6B | $1.9B | $1.5B | $1.5B | $1.4B |
| SG&A Expense | $5.8B | $5.7B | $5.4B | $5.3B | $5.7B | $4.9B | $5.4B | $4.9B |
| Operating Income | $3.2B | $3.8B | $3.5B | $4.7B | $5.3B | $3.5B | $3.9B | $4.1B |
| Net Income | $2.5B | $2.8B | $3.3B | $3.2B | $6.5B | $2.8B | $3.2B | $5.3B |
| EPS (Basic) | $2.67 | $2.83 | $3.29 | $3.09 | $5.38 | $2.01 | $2.08 | $3.30 |
| EPS (Diluted) | $2.65 | $2.81 | $3.26 | $3.05 | $5.33 | $2.00 | $2.07 | $3.26 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $41.8B | $39.9B | $37.0B | $38.6B | $38.6B | $34.7B | $33.5B | $34.6B |
| Current Assets | $22.5B | $20.8B | $18.0B | $19.8B | $22.2B | $20.6B | $20.2B | $21.4B |
| Cash & Equivalents | $3.7B | $3.2B | $3.1B | $3.1B | $4.3B | $4.9B | $4.5B | $5.2B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $29.3B | $28.7B | $24.5B | $26.2B | $29.1B | $26.2B | $25.3B | $25.1B |
| Stockholders' Equity | $-0.3B | $-1.3B | $-1.1B | $-2.9B | $-1.6B | $-2.2B | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $3.7B | $3.7B | $3.6B | $4.5B | $6.4B | $4.3B | $4.7B | $4.5B |
| Investing Cash Flow | $-1.2B | $-0.6B | $-0.6B | $-3.5B | $-1.0B | $-1.0B | $-0.4B | $-0.7B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-2.1B | $-3.1B | $-2.9B | $-2.1B | $-6.0B | $-3.0B | $-4.8B | $-5.6B |